Innovative Oral Treatment Options for Patients

Written by patrippon on October 13, 2020.

When

10/13/20

6:30 pm - 8:00 pm

Innovative Oral Treatment Options for Patients: HR+/HER2- mBC or gBRCA-Mutated
Triple-Negative and HR+/HER2- mBC – A virtual Event

Presented by:
ANDREW SEIDMAN MD
Attending Physician, Breast Medicine Service
Medical Director, Bobst International Center
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College

Please RSVP to your Pfizer Representative
Dahlia Mann: (310) 422-7978, dahlia.mann@pfizer.com

Kindly provide your full name, degree, specialty, address including state, and email address when registering so that you can be confirmed. Please also reference Meeting ID# INT-0061719

Click here for more information.